The Ozempic Impact – Designing for Dramatically Different Dining

SHOW NOTES – EPISODE 118

Episode Summary: This groundbreaking episode examines how GLP-1 drugs like Ozempic are fundamentally transforming club dining, from kitchen economics to social dynamics, and explores innovative solutions for clubs facing this pharmaceutical revolution.

Key Topics Covered:

• The scope of GLP-1 drug adoption among members
• Collapsing kitchen economics with 30-40% reduced consumption
• Social dining crisis and member discomfort
• Design modifications for new dining realities
• Innovative programming and pricing solutions
• Future implications for club F&B programs

The Numbers That Matter:

• 15-20% of affluent Americans currently using GLP-1 drugs
• 30-40% projected adoption within 3 years
• 35% average check decline reported by clubs
• 70% reduction in individual food consumption
• 60% food waste in traditional prep models
• 20% of F&B revenue shifting to takeout

Economic Impacts:

• Traditional cost structure (30-35% food, 40-45% labor) unsustainable
• Average per-cover loss: $12 for GLP-1 users
• Buffet model economics completely broken
• Catering guarantees no longer reliable
• Beverage programs facing reduced tolerance issues

Design Adaptations:

Physical Modifications:

• Smaller plate sizes (7-inch vs 12-inch)
• Flexible table systems
• “Jewelry box” buffet presentations
• Adjustable atmospheric lighting
• Smaller kitchen prep areas
• Precision cooking equipment for tiny portions

Service Model Changes:

• Tapas-style flexible timing
• “Collections” menu format
• Experience-focused presentations
• Tableside theater emphasis
• Parallel wellness/traditional programs

Innovative Solutions:

• Experience fees vs food charges
• Membership-inclusive dining credits
• Sophisticated mocktail programs
• Zero-proof wine pairings
• Educational programming emphasis
• Expanded takeout operations

Social Dynamics:

• “Eaters” vs “non-eaters” divide
• Generational tensions over pharmaceutical use
• Celebration challenges with non-eating guests
• Wine culture crisis
• Business dining confusion
• Staff morale impacts

Future Implications:

• Oral GLP-1 drugs will increase adoption
• Dining rooms becoming “social galleries”
• Staffing shift to nutrition specialists
• Technology for mass customization
• Fundamental questioning of F&B role

Immediate Action Items:

1. Anonymous member survey on GLP-1 usage
2. F&B vulnerability audit
3. Small-plate program pilot
4. Alternative pricing model exploration
5. Staff training on pharmaceutical impacts
6. Menu engineering for variety over volume

Design Recommendations:

• Invest in smaller serviceware
• Create flexible dining spaces
• Develop “social lounges” vs formal dining
• Plan kitchens for variety not volume
• Design for experience over consumption
• Enable multiple service models simultaneously

Key Insights: “We’re not just feeding bodies anymore – we’re nourishing communities in entirely new ways.”

“The successful clubs will recognize dining as social theater where food is prop, not purpose.”

“This isn’t a trend to weather – it’s a fundamental shift in human behavior driven by pharmaceutical intervention.”

Warning Signs to Monitor:

• Declining average checks
• Increased food waste
• Member complaints about portions
• Staff morale issues
• Event attendance dropping
• Bar liability incidents

Connect With Us:

• Website: golfclubhousedesign.com
• LinkedIn: linkedin.com/in/egcd/
• Listen on Fountain: fountain.fm/show/yzI5IQdvhrChoCRj3htR